Novo Nordisk Aktie
99,55
EUR
-3,13
EUR
-3,05
%
94,41
CHF
-2,24
CHF
-2,32
%
Novo Nordisk Aktie Analyse
04.10.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
03.10.22 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
03.10.22 | Novo Nordisk Overweight | Barclays Capital | |
21.09.22 | Novo Nordisk Buy | Deutsche Bank AG | |
23.08.22 | Novo Nordisk Sell | UBS AG | |
22.08.22 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
17.08.22 | Novo Nordisk Sell | UBS AG | |
15.08.22 | Novo Nordisk Overweight | Barclays Capital | |
Werbung
|
|||
05.08.22 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
05.08.22 | Novo Nordisk Buy | Deutsche Bank AG | |
05.08.22 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
04.08.22 | Novo Nordisk Neutral | Credit Suisse Group | |
04.08.22 | Novo Nordisk Overweight | Barclays Capital | |
03.08.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
03.08.22 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
03.08.22 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
18.07.22 | Novo Nordisk Overweight | Barclays Capital | |
14.07.22 | Novo Nordisk Outperform | Bernstein Research | |
13.07.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
11.07.22 | Novo Nordisk Neutral | Credit Suisse Group | |
28.06.22 | Novo Nordisk Sell | UBS AG | |
24.06.22 | Novo Nordisk Neutral | UBS AG | |
24.06.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
21.06.22 | Novo Nordisk Buy | Deutsche Bank AG | |
16.06.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
13.06.22 | Novo Nordisk Overweight | Barclays Capital | |
08.06.22 | Novo Nordisk Buy | Deutsche Bank AG | |
07.06.22 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
06.06.22 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
03.06.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
27.05.22 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
24.05.22 | Novo Nordisk Buy | Deutsche Bank AG | |
20.05.22 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
12.05.22 | Novo Nordisk Overweight | Barclays Capital | |
11.05.22 | Novo Nordisk Buy | Deutsche Bank AG | |
05.05.22 | Novo Nordisk Outperform | Bernstein Research | |
05.05.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
04.05.22 | Novo Nordisk Buy | Deutsche Bank AG | |
03.05.22 | Novo Nordisk Buy | Deutsche Bank AG | |
29.04.22 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
29.04.22 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
29.04.22 | Novo Nordisk Outperform | Bernstein Research | |
29.04.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
28.04.22 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
27.04.22 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
21.04.22 | Novo Nordisk Outperform | Bernstein Research | |
19.04.22 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
14.04.22 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
12.04.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
01.04.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. |